S. Çelik Et Al. , "SECONDARY HYPOGAMMAGLOBULINEMIA INPATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIARECEIVING IBRUTINIB THERAPY," 25th Congress of theEuropean HematologyAssociation , pp.874, 2020
Çelik, S. Et Al. 2020. SECONDARY HYPOGAMMAGLOBULINEMIA INPATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIARECEIVING IBRUTINIB THERAPY. 25th Congress of theEuropean HematologyAssociation , 874.
Çelik, S., Güven, Z. T., Ünal, A., & Kaynar, L., (2020). SECONDARY HYPOGAMMAGLOBULINEMIA INPATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIARECEIVING IBRUTINIB THERAPY . 25th Congress of theEuropean HematologyAssociation (pp.874).
Çelik, SERHAT Et Al. "SECONDARY HYPOGAMMAGLOBULINEMIA INPATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIARECEIVING IBRUTINIB THERAPY," 25th Congress of theEuropean HematologyAssociation, 2020
Çelik, SERHAT Et Al. "SECONDARY HYPOGAMMAGLOBULINEMIA INPATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIARECEIVING IBRUTINIB THERAPY." 25th Congress of theEuropean HematologyAssociation , pp.874, 2020
Çelik, S. Et Al. (2020) . "SECONDARY HYPOGAMMAGLOBULINEMIA INPATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIARECEIVING IBRUTINIB THERAPY." 25th Congress of theEuropean HematologyAssociation , p.874.
@conferencepaper{conferencepaper, author={SERHAT ÇELİK Et Al. }, title={SECONDARY HYPOGAMMAGLOBULINEMIA INPATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIARECEIVING IBRUTINIB THERAPY}, congress name={25th Congress of theEuropean HematologyAssociation}, city={}, country={}, year={2020}, pages={874} }